Medimmune Limited

Paul Warrener

Ralph Raymond Minter

Charles K Stover

Sandrine Guillard

Steven Rust

Antonio Digiandomenico

Mladen Tomich

Bret Sellman

Changshou Gao

Partha S Chowdhury

Nazzareno Dimasi

Reena Varkey

Ryan Fleming

Binyam Bezabeh

Vignesh Venkatraman

Melissa Marie Damschroder

Godfrey Rainey

Cuihua Gao

Li Peng

Brett R Sellman

Rust Steven

Ralph Minter

This disclosure relates to combination therapies comprising anti-Psl and PcrV binding molecules and related compositions, for use in prevention and treatment ofinfection.

Combination therapies using anti-pseudomonas PSL and PCRV binding molecules

This disclosure relates to polynucleotides encoding antibodies or antigen binding fragments thereof that bind toPcrV as well as vectors and host cells comprising the same.

Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv

This disclosure relates to an anti-Psl binding molecule and uses thereof, in particular in prevention and treatment ofinfection. Furthermore, the disclosure provides compositions and methods for preventing and treatinginfection.

Anti-Psl binding molecules and uses thereof

The disclosure relates to an anti-PSL binding molecule and uses thereof, in particular, in prevention and treatment ofinfection. Furthermore, the disclosure provides compositions and methods for preventing and treatinginfection.

Anti-pseudomonas Psl binding molecules and uses thereof

The disclosure generally provides proteins that bind two epitopes (e.g., a first and a second epitope) and that are bivalent for binding to each of the first and second epitopes. The disclosure also provides compositions comprising such proteins, nucleic acid molecules encoding such proteins and methods of making and using such proteins.

Multispecific and multivalent binding proteins and uses thereof

Growing community of inventors

Gaithersburg, MD, United States of America

Paul Warrener